Quay Pharma is now part of sgs logoopens in a new window


Company Overview


Over ten years of extensive development and manufacture experience converting controlled substances.

Read MoreWatch Now

At Quay Pharmaceuticals, we have over 10 years of extensive development and manufacturing experience converting controlled substances into a variety of different dosage forms.

Therefore, you can have complete assurance in our proficiency to deliver your project with controlled substances quickly and efficiently.

Our Deeside facility is fully licensed by the UK Home Office to possess, produce and supply controlled substances covering schedules I to IV (parts I and II). As required by the Home Office, the Deeside site has the required physical security processes as well as tightly controlled procedures, administrative controls, and accountability processes that are carried out by experienced, highly qualified staff.

Quay has worked with both synthetic and plant extract controlled materials and arranged import or export licences with the UK’s Drugs and Firearms Licensing Unit as required to move controlled substances or products across state boundaries.

Examples of Quay’s development of controlled substances:

  • Schedule I controlled substance for clinical trial use
  • Schedule II controlled substance for commercial use
  • Schedule IV controlled substance for Specials Supply
Your Dedicated Contacts
David Blum
Managing Director (Israel)
Contact Contact
Michael Kruidenier
Head of Business Development
Contact Contact
Our Pharmaceutical Services

Drug Development Services

SGS PACE (Product Accelerated Clinically Enabled) helps you bring the vision of your new drug to life - Faster.

Find Out More

Preclinical Formulation

Robust formulation development strategies tailored to the characteristics of each individual API.

Find Out More


Analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges.

Find Out More

Pharmaceutical Formulation Development

Dosage form optimisation for a wide range of product types including those that have poor solubility or bioavailability.

Find Out More

Analytical Services

Analytical specialists working alongside our formulation and manufacturing teams which provide expert advice.

Find Out More

Phase I Clinical Manufacturing

Early clinical formulations and clinical manufacturing of First in Human trials and clinical evaluations of your API.

Find Out More

Phase II & III Clinical Manufacturing

Fully equipped and accredited to manufacture a wide range of products for Phase II and small-scale Phase III trials.

Find Out More

Commercial Manufacturing

MHRA licensed to include commercial manufacture. Services include contract packaging and assembly...

Find Out More

Controlled Substances

Over ten years of extensive development and manufacture experience converting controlled substances into a variety of different dosage forms.

Find Out More

Clinical Trial Supply

Complete range of clinical trial supply packaging for solid and liquid dosages. Despatched with full QP release certification.

Find Out More

Live Biotherapeutics Drug Delivery

One of the few companies licensed for the clinical manufacture of live biotherapeutics products.

Find Out More

Orphan Drugs

Perfectly equipped to deliver an Orphan Drug molecule from preclinical and formulation development to small scale commercialisation.

Find Out More

Specials Manufacturing

One of the limited number of contract manufacturers who hold an MRHA license for the manufacture and supply of ‘specials’.

Find Out More

Let's Talk Project Success

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us